世界の鼻内噴霧用コルチコステロイド市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Intranasal Corticosteroids Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4391
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、鼻内噴霧用コルチコステロイドの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（処方薬、OTC薬）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・鼻内噴霧用コルチコステロイドの市場動向
・企業の競争状況、市場シェア
・鼻内噴霧用コルチコステロイドの種類別市場規模と予測2016-2027（処方薬、OTC薬）
・鼻内噴霧用コルチコステロイドの用途別市場規模と予測2016-2027（病院薬局、オンライン薬局、小売薬局）
・鼻内噴霧用コルチコステロイドの北米市場規模2016-2027（アメリカ、カナダ）
・鼻内噴霧用コルチコステロイドの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・鼻内噴霧用コルチコステロイドのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・鼻内噴霧用コルチコステロイドの中南米市場規模2016-2027（メキシコ、ブラジル）
・鼻内噴霧用コルチコステロイドの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、Merck、Sanofi、SUMITOMO、Teva、Johnson & Johnson、AstraZeneca）
・結論

Intranasal corticosteroids are the only potent and effective drugs which are used to treat various nasal complications such as nasal-polyps, nasal-rhinitis and chronic sinusitis.

Market Analysis and Insights: Global Intranasal Corticosteroids Market
The global Intranasal Corticosteroids market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intranasal Corticosteroids market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intranasal Corticosteroids market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intranasal Corticosteroids market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intranasal Corticosteroids market.

Global Intranasal Corticosteroids Scope and Market Size
Intranasal Corticosteroids market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intranasal Corticosteroids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prescribed Drugs
OTC Drugs

Segment by Application
Hospital Pharmacies
Online Pharnacies
Retail Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Merck
Sanofi
SUMITOMO
Teva
Johnson & Johnson
AstraZeneca

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intranasal Corticosteroids Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescribed Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Intranasal Corticosteroids Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharnacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Intranasal Corticosteroids Market Perspective (2016-2027)
2.2 Intranasal Corticosteroids Growth Trends by Regions
2.2.1 Intranasal Corticosteroids Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Intranasal Corticosteroids Historic Market Share by Regions (2016-2021)
2.2.3 Intranasal Corticosteroids Forecasted Market Size by Regions (2022-2027)
2.3 Intranasal Corticosteroids Industry Dynamic
2.3.1 Intranasal Corticosteroids Market Trends
2.3.2 Intranasal Corticosteroids Market Drivers
2.3.3 Intranasal Corticosteroids Market Challenges
2.3.4 Intranasal Corticosteroids Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Intranasal Corticosteroids Players by Revenue
3.1.1 Global Top Intranasal Corticosteroids Players by Revenue (2016-2021)
3.1.2 Global Intranasal Corticosteroids Revenue Market Share by Players (2016-2021)
3.2 Global Intranasal Corticosteroids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Intranasal Corticosteroids Revenue
3.4 Global Intranasal Corticosteroids Market Concentration Ratio
3.4.1 Global Intranasal Corticosteroids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intranasal Corticosteroids Revenue in 2020
3.5 Intranasal Corticosteroids Key Players Head office and Area Served
3.6 Key Players Intranasal Corticosteroids Product Solution and Service
3.7 Date of Enter into Intranasal Corticosteroids Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Intranasal Corticosteroids Breakdown Data by Type
4.1 Global Intranasal Corticosteroids Historic Market Size by Type (2016-2021)
4.2 Global Intranasal Corticosteroids Forecasted Market Size by Type (2022-2027)

5 Intranasal Corticosteroids Breakdown Data by Application
5.1 Global Intranasal Corticosteroids Historic Market Size by Application (2016-2021)
5.2 Global Intranasal Corticosteroids Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Intranasal Corticosteroids Market Size (2016-2027)
6.2 North America Intranasal Corticosteroids Market Size by Type
6.2.1 North America Intranasal Corticosteroids Market Size by Type (2016-2021)
6.2.2 North America Intranasal Corticosteroids Market Size by Type (2022-2027)
6.2.3 North America Intranasal Corticosteroids Market Size by Type (2016-2027)
6.3 North America Intranasal Corticosteroids Market Size by Application
6.3.1 North America Intranasal Corticosteroids Market Size by Application (2016-2021)
6.3.2 North America Intranasal Corticosteroids Market Size by Application (2022-2027)
6.3.3 North America Intranasal Corticosteroids Market Size by Application (2016-2027)
6.4 North America Intranasal Corticosteroids Market Size by Country
6.4.1 North America Intranasal Corticosteroids Market Size by Country (2016-2021)
6.4.2 North America Intranasal Corticosteroids Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Intranasal Corticosteroids Market Size (2016-2027)
7.2 Europe Intranasal Corticosteroids Market Size by Type
7.2.1 Europe Intranasal Corticosteroids Market Size by Type (2016-2021)
7.2.2 Europe Intranasal Corticosteroids Market Size by Type (2022-2027)
7.2.3 Europe Intranasal Corticosteroids Market Size by Type (2016-2027)
7.3 Europe Intranasal Corticosteroids Market Size by Application
7.3.1 Europe Intranasal Corticosteroids Market Size by Application (2016-2021)
7.3.2 Europe Intranasal Corticosteroids Market Size by Application (2022-2027)
7.3.3 Europe Intranasal Corticosteroids Market Size by Application (2016-2027)
7.4 Europe Intranasal Corticosteroids Market Size by Country
7.4.1 Europe Intranasal Corticosteroids Market Size by Country (2016-2021)
7.4.2 Europe Intranasal Corticosteroids Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Intranasal Corticosteroids Market Size (2016-2027)
8.2 Asia-Pacific Intranasal Corticosteroids Market Size by Type
8.2.1 Asia-Pacific Intranasal Corticosteroids Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Intranasal Corticosteroids Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Intranasal Corticosteroids Market Size by Type (2016-2027)
8.3 Asia-Pacific Intranasal Corticosteroids Market Size by Application
8.3.1 Asia-Pacific Intranasal Corticosteroids Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Intranasal Corticosteroids Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Intranasal Corticosteroids Market Size by Application (2016-2027)
8.4 Asia-Pacific Intranasal Corticosteroids Market Size by Region
8.4.1 Asia-Pacific Intranasal Corticosteroids Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Intranasal Corticosteroids Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Intranasal Corticosteroids Market Size (2016-2027)
9.2 Latin America Intranasal Corticosteroids Market Size by Type
9.2.1 Latin America Intranasal Corticosteroids Market Size by Type (2016-2021)
9.2.2 Latin America Intranasal Corticosteroids Market Size by Type (2022-2027)
9.2.3 Latin America Intranasal Corticosteroids Market Size by Type (2016-2027)
9.3 Latin America Intranasal Corticosteroids Market Size by Application
9.3.1 Latin America Intranasal Corticosteroids Market Size by Application (2016-2021)
9.3.2 Latin America Intranasal Corticosteroids Market Size by Application (2022-2027)
9.3.3 Latin America Intranasal Corticosteroids Market Size by Application (2016-2027)
9.4 Latin America Intranasal Corticosteroids Market Size by Country
9.4.1 Latin America Intranasal Corticosteroids Market Size by Country (2016-2021)
9.4.2 Latin America Intranasal Corticosteroids Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Intranasal Corticosteroids Market Size (2016-2027)
10.2 Middle East & Africa Intranasal Corticosteroids Market Size by Type
10.2.1 Middle East & Africa Intranasal Corticosteroids Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Intranasal Corticosteroids Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Intranasal Corticosteroids Market Size by Type (2016-2027)
10.3 Middle East & Africa Intranasal Corticosteroids Market Size by Application
10.3.1 Middle East & Africa Intranasal Corticosteroids Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Intranasal Corticosteroids Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Intranasal Corticosteroids Market Size by Application (2016-2027)
10.4 Middle East & Africa Intranasal Corticosteroids Market Size by Country
10.4.1 Middle East & Africa Intranasal Corticosteroids Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Intranasal Corticosteroids Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Intranasal Corticosteroids Introduction
11.1.4 GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Intranasal Corticosteroids Introduction
11.2.4 Merck Revenue in Intranasal Corticosteroids Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Intranasal Corticosteroids Introduction
11.3.4 Sanofi Revenue in Intranasal Corticosteroids Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 SUMITOMO
11.4.1 SUMITOMO Company Details
11.4.2 SUMITOMO Business Overview
11.4.3 SUMITOMO Intranasal Corticosteroids Introduction
11.4.4 SUMITOMO Revenue in Intranasal Corticosteroids Business (2016-2021)
11.4.5 SUMITOMO Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Intranasal Corticosteroids Introduction
11.5.4 Teva Revenue in Intranasal Corticosteroids Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Intranasal Corticosteroids Introduction
11.6.4 Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Intranasal Corticosteroids Introduction
11.7.4 AstraZeneca Revenue in Intranasal Corticosteroids Business (2016-2021)
11.7.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Intranasal Corticosteroids Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescribed Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Intranasal Corticosteroids Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Intranasal Corticosteroids Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Intranasal Corticosteroids Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Intranasal Corticosteroids Market Share by Regions (2016-2021)
Table 8. Global Intranasal Corticosteroids Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Intranasal Corticosteroids Market Share by Regions (2022-2027)
Table 10. Intranasal Corticosteroids Market Trends
Table 11. Intranasal Corticosteroids Market Drivers
Table 12. Intranasal Corticosteroids Market Challenges
Table 13. Intranasal Corticosteroids Market Restraints
Table 14. Global Intranasal Corticosteroids Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Intranasal Corticosteroids Market Share by Players (2016-2021)
Table 16. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intranasal Corticosteroids as of 2020)
Table 17. Ranking of Global Top Intranasal Corticosteroids Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Intranasal Corticosteroids Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intranasal Corticosteroids Product Solution and Service
Table 21. Date of Enter into Intranasal Corticosteroids Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intranasal Corticosteroids Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Intranasal Corticosteroids Revenue Market Share by Type (2016-2021)
Table 25. Global Intranasal Corticosteroids Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Intranasal Corticosteroids Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Intranasal Corticosteroids Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Intranasal Corticosteroids Revenue Market Share by Application (2016-2021)
Table 29. Global Intranasal Corticosteroids Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Intranasal Corticosteroids Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Intranasal Corticosteroids Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Intranasal Corticosteroids Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Intranasal Corticosteroids Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Intranasal Corticosteroids Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Intranasal Corticosteroids Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Intranasal Corticosteroids Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Intranasal Corticosteroids Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Intranasal Corticosteroids Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Intranasal Corticosteroids Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Intranasal Corticosteroids Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Intranasal Corticosteroids Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Intranasal Corticosteroids Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Intranasal Corticosteroids Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Intranasal Corticosteroids Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Intranasal Corticosteroids Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Intranasal Corticosteroids Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Intranasal Corticosteroids Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Intranasal Corticosteroids Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Intranasal Corticosteroids Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Intranasal Corticosteroids Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Intranasal Corticosteroids Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Intranasal Corticosteroids Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Intranasal Corticosteroids Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Intranasal Corticosteroids Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Intranasal Corticosteroids Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Intranasal Corticosteroids Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Intranasal Corticosteroids Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Intranasal Corticosteroids Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Intranasal Corticosteroids Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Intranasal Corticosteroids Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Intranasal Corticosteroids Product
Table 64. GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Intranasal Corticosteroids Product
Table 69. Merck Revenue in Intranasal Corticosteroids Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Intranasal Corticosteroids Product
Table 74. Sanofi Revenue in Intranasal Corticosteroids Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. SUMITOMO Company Details
Table 77. SUMITOMO Business Overview
Table 78. SUMITOMO Intranasal Corticosteroids Product
Table 79. SUMITOMO Revenue in Intranasal Corticosteroids Business (2016-2021) & (US$ Million)
Table 80. SUMITOMO Recent Development
Table 81. Teva Company Details
Table 82. Teva Business Overview
Table 83. Teva Intranasal Corticosteroids Product
Table 84. Teva Revenue in Intranasal Corticosteroids Business (2016-2021) & (US$ Million)
Table 85. Teva Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Intranasal Corticosteroids Product
Table 89. Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Intranasal Corticosteroids Product
Table 94. AstraZeneca Revenue in Intranasal Corticosteroids Business (2016-2021) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intranasal Corticosteroids Market Share by Type: 2020 VS 2027
Figure 2. Prescribed Drugs Features
Figure 3. OTC Drugs Features
Figure 4. Global Intranasal Corticosteroids Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharnacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Intranasal Corticosteroids Report Years Considered
Figure 9. Global Intranasal Corticosteroids Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Intranasal Corticosteroids Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Intranasal Corticosteroids Market Share by Regions: 2020 VS 2027
Figure 12. Global Intranasal Corticosteroids Market Share by Regions (2022-2027)
Figure 13. Global Intranasal Corticosteroids Market Share by Players in 2020
Figure 14. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intranasal Corticosteroids as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Intranasal Corticosteroids Revenue in 2020
Figure 16. Global Intranasal Corticosteroids Revenue Market Share by Type (2016-2021)
Figure 17. Global Intranasal Corticosteroids Revenue Market Share by Type (2022-2027)
Figure 18. North America Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Intranasal Corticosteroids Market Share by Type (2016-2027)
Figure 20. North America Intranasal Corticosteroids Market Share by Application (2016-2027)
Figure 21. North America Intranasal Corticosteroids Market Share by Country (2016-2027)
Figure 22. United States Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Intranasal Corticosteroids Market Share by Type (2016-2027)
Figure 26. Europe Intranasal Corticosteroids Market Share by Application (2016-2027)
Figure 27. Europe Intranasal Corticosteroids Market Share by Country (2016-2027)
Figure 28. Germany Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Intranasal Corticosteroids Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Intranasal Corticosteroids Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Intranasal Corticosteroids Market Share by Region (2016-2027)
Figure 38. China Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Intranasal Corticosteroids Market Share by Type (2016-2027)
Figure 46. Latin America Intranasal Corticosteroids Market Share by Application (2016-2027)
Figure 47. Latin America Intranasal Corticosteroids Market Share by Country (2016-2027)
Figure 48. Mexico Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Intranasal Corticosteroids Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Intranasal Corticosteroids Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Intranasal Corticosteroids Market Share by Country (2016-2027)
Figure 54. Turkey Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Intranasal Corticosteroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Intranasal Corticosteroids Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Intranasal Corticosteroids Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Intranasal Corticosteroids Business (2016-2021)
Figure 60. SUMITOMO Revenue Growth Rate in Intranasal Corticosteroids Business (2016-2021)
Figure 61. Teva Revenue Growth Rate in Intranasal Corticosteroids Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Intranasal Corticosteroids Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Intranasal Corticosteroids Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

鼻腔内用ドラッグデリバリーデバイスのグローバル市場2021

Global Intranasal Drug Delivery Devices Sales Market Report 2021
QAF27238 2021年4月6日 134Pages
本市場調査資料では、世界の鼻腔内用ドラッグデリバリーデバイス市場について種類別（マルチドーズ、ユニ/ビドース）、用途別（個人用、病院用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要...

世界のCOPD治療薬市場規模・現状・予測（2021年-2027年）

Global COPD Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5676 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、COPD治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、吸入コルチコステロイド、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のCOPD用治療薬市場規模・現状・予測（2021年-2027年）

Global COPD Medication Market Size, Status and Forecast 2021-2027
QFJ1-5675 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、COPD用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（短時間作用型気管支拡張薬、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張薬、併用薬）、用途別市場規模（病院、診療所、薬局、...

世界の鼻ポリープ治療薬市場規模・現状・予測（2021年-2027年）

Global Nasal Polyps Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4549 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、鼻ポリープ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗生物質、ロイコトリエン阻害剤、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の免疫性血小板減少症治療薬市場規模・現状・予測（2021年-2027年）

Global Immune Thrombocytopenia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5797 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、免疫性血小板減少症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（トロンボポエチン受容体作動薬 (TPO-RAs)、コルチコステロイド、静脈免疫グロブリン (IVIGs)、その他薬剤）、用途別市...

世界のアルコール性肝炎治療市場規模・現状・予測（2021年-2027年）

Global Alcoholic Hepatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3776 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、アルコール性肝炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、キサンチン誘導体、その他）、用途別市場規模（病院、診療所、私立治療センター）、主要地域別市場規模（北米、アメリカ...

世界のアテローム性動脈硬化症薬剤市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3866 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、PDE4阻害剤、生物製剤、皮膚バリアエモリエント、CNI免疫抑制剤、その他）、用途別市場規模（病院、診療所...

世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Goodpasture Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5758 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、グッドパスチャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の皮膚科治療市場規模・現状・予測（2021年-2027年）

Global Dermatological Remedies Market Size, Status and Forecast 2021-2027
QFJ1-5698 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、皮膚科治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗感染薬、コルチコステロイド、抗乾癬、抗ニキビ、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

鼻腔内用ドラッグデリバリーデバイスのグローバル市場2021 Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through n…
ステロイド-コルチコステロイドのグローバル市場2021 Steroid-Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. The steroid-corticosteroids market is concentrated; the revenue of top nine manufacturers accounts about 86% of the total revenue. The…
世界の移植治療薬市場規模・現状・予測（2021年-2027年） Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body. Market Analysis and Insights: Global Transplantation Therapeutics Drugs Market The global Transplantation Therapeutics Drugs market size is…
世界の皮膚線維症治療薬市場規模・現状・予測（2021年-2027年） Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β,186. This growth factor maybe derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of e…
世界のアテローム性動脈硬化症薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Atherosclerosis Drugs Market The global Atherosclerosis Drugs market size is projected to reach US$ 43670 million by 2027, from US$ 38400 million in 2020, at a CAGR of 1.4% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the…